Logo image of MOBX

MOBIX LABS INC (MOBX) Stock Fundamental Analysis

NASDAQ:MOBX - Nasdaq - US60743G1004 - Common Stock - Currency: USD

1.11  -0.02 (-1.77%)

Premarket: 1.17 +0.06 (+5.41%)

Fundamental Rating

0

Overall MOBX gets a fundamental rating of 0 out of 10. We evaluated MOBX against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. MOBX may be in some trouble as it scores bad on both profitability and health. MOBX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MOBX had negative earnings in the past year.
MOBX had a negative operating cash flow in the past year.
MOBX Yearly Net Income VS EBIT VS OCF VS FCFMOBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -500K -1M

1.2 Ratios

MOBX has a worse Return On Assets (-62.95%) than 89.72% of its industry peers.
With a Return On Equity value of -447.10%, MOBX is not doing good in the industry: 92.52% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -62.95%
ROE -447.1%
ROIC N/A
ROA(3y)-5.03%
ROA(5y)N/A
ROE(3y)-6.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MOBX Yearly ROA, ROE, ROICMOBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -2 -4 -6 -8 -10

1.3 Margins

MOBX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MOBX Yearly Profit, Operating, Gross MarginsMOBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, MOBX has about the same amount of shares outstanding.
MOBX has a worse debt/assets ratio than last year.
MOBX Yearly Shares OutstandingMOBX Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M 8M
MOBX Yearly Total Debt VS Total AssetsMOBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

MOBX has an Altman-Z score of -8.07. This is a bad value and indicates that MOBX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -8.07, MOBX is not doing good in the industry: 81.31% of the companies in the same industry are doing better.
MOBX has a Debt/Equity ratio of 0.76. This is a neutral value indicating MOBX is somewhat dependend on debt financing.
MOBX's Debt to Equity ratio of 0.76 is on the low side compared to the rest of the industry. MOBX is outperformed by 81.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z -8.07
ROIC/WACCN/A
WACCN/A
MOBX Yearly LT Debt VS Equity VS FCFMOBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.25 indicates that MOBX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.25, MOBX is doing worse than 97.20% of the companies in the same industry.
A Quick Ratio of 0.23 indicates that MOBX may have some problems paying its short term obligations.
The Quick ratio of MOBX (0.23) is worse than 97.20% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.23
MOBX Yearly Current Assets VS Current LiabilitesMOBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

MOBX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.30%.
EPS 1Y (TTM)-6.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.37%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MOBX Yearly Revenue VS EstimatesMOBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
MOBX Yearly EPS VS EstimatesMOBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MOBX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOBX Price Earnings VS Forward Price EarningsMOBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MOBX Per share dataMOBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MOBX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MOBIX LABS INC

NASDAQ:MOBX (2/26/2025, 8:00:01 PM)

Premarket: 1.17 +0.06 (+5.41%)

1.11

-0.02 (-1.77%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners22.85%
Inst Owner Change-54.76%
Ins Owners25.33%
Ins Owner Change2.2%
Market Cap40.98M
AnalystsN/A
Price TargetN/A
Short Float %4.36%
Short Ratio0.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 21.09
P/FCF N/A
P/OCF N/A
P/B 9.87
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.71
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0.05
BVpS0.11
TBVpS-0.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -62.95%
ROE -447.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.03%
ROA(5y)N/A
ROE(3y)-6.68%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.23
Altman-Z -8.07
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)83.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%4.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3204.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1893.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1843.66%
OCF growth 3YN/A
OCF growth 5YN/A